HS Code Export Data of India History Records | India Exports History Records under HS Code 224900

1X40 HC REF 2249 CARTONS PACK ED IN 35 PALLETS PHARMACEUTIC ALS AS UNDER ROPINIROLE TABS 5MG 100 S NDC CODE:6846202590 1 FDA PRODUCT CODE NO.:62 J C A 17 H. T. S NO.: 3004.90.92 .40 ANDA NO.:- 90-135 THERAP 1X40 REF 320 CARTONS PACKED I N 7 PALLETS PHARMACEUTICALS A S UNDER ADAPALENE GEL 0.1% 15 GM (PLD) NDC CODE:69842008805 NDC NO.:69842008805 FDA PRO DUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA EUTICE USE:-TREATMENT OF PARK INSONISM ROPINIROLE TABS 3MG 100 S NDC CODE:68462025701 F DA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPE UTICE USE:-TREATMENT OF PARKI NSONISM PRAMIPEXOLE TABS 0.5M G 90 S NDC CODE:68462033290 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.4 0 ANDA NO.: 90-781 THERAPEUT ICE USE: USED IN PARKINSON#S DISEASE OXCARBAZEPINE TABLETS 600MG 100 S NDC CODE:6846201 3901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9 0.92.30 ANDA NO.:-77-802 THE RAPEUTICE USE:-ANTI CONVULSANT AGENT OMEPRAZOLE DR CAPSULES 10MG 100 S NDC CODE:68462039 501 FDA PRODUCT CODE NO.: 62K CF10 H. T. S NO.: 3004.90.916 0 ANDA NO.: 91672 THERAPEUTI CE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OMEPRAZOLE DR CAPSULES 10M G 30 S NDC CODE:68462039530 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 AN DA NO.: 91672 THERAPEUTICE US E: - TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE POTASSIUM CL ER TAB 20MEQ (15 00MG) 100 S NDC CODE:68462047 201 FDA PRODUCT CODE NO.: 65 R C A 14 H. T. S NO.: 3004. 90.9190 ANDA NO.: 203562 THE RAPEUTICE USE: - TO TREAT OR PREVENT LOW AMOUNTS OF POTASS IUM IN THE BLOOD OMEPRAZOLE DR CAPSULES 20MG 1000 S NDC C ODE:68462039610 FDA PRODUCT C ODE NO.: 62KCF10 H. T. S NO. : 3004.90.9160 ANDA NO.: 916 72 THERAPEUTICE USE: - TREAT MENT OF TREAT GASTROESOPHAGEA L REFLUX DISEASE GROSS WT.: 8,791.96 KGS NET WT.: 7,550.6 4 KGS COMMERCIAL & CUSTOM INV OICE NO. F22252005782 DT. 23. 02.2022 F22252005791 DT. 23.0 2.2022 F22252005815 DT. 24.02 .2022 SB NO.: 8492699 DT.: 24 /02/22 SB NO.: 8494162 DT.: 2 5/02/22 SB NO.: 8515041 DT.: 25/02/22 03 DATA LOGGERS S ET TEMPERATURE : +20 DEGREES CONTAINER NO. MNBU4115887 MAN UFACTURE D FOR GLENMARK PHA RMACEUTICAL S INC., USA 301, ISLAND RD MAHWAH MNBU411588 7 ML-IN4125979 40 REEF 9 6 35 PACKAGE 8791.960 KGS TEMPERAT URE: 20.0 C CUSTOMS SEAL : KL IK20081690 THE PLACE OF ISSUA NCE OF THIS DOCUMENT SHALL BE DEEMED TO BE THE MAERSK LINE I NDIA PVT LTD OFFICE LOCATED E ITHER IN THE SAME STATE OR THE NEAREST STATE WITH RESPECT TO THE ABOVE REFERENCED CARGO P ICK-UP / DROP-OFF LOCATION GO ODS SHIPPED IN REFRIGERATED CO NTAINER(S) SET AT SHIPPER S RE QUESTED CARRIAGE TEMPERATURE AS PER ABOVE SHIPPER S LOAD, STOW, WEIGHT AND COUNT FREI GHT PREPAID ALSO NOTIFY: GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA CY/CY NO.: 091314 THERAPEUTICE USE : - TREATMENT OF ACNE ADAPALE NE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 NDC NO.:6984 2008816 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 300 4.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE 00 DATA LOGGERS CO NTAINER NO. MNBU9046937 NET W T: 1,126.69 KGS GROSS WT: 1,6 26.72 KGS COMMERCIAL & CUSTOM INVOICE NO. F22252005775 DT. 23.02.2022 F22252005776 DT. 23.02.2022